These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 32361709)
1. Atypical Hemolytic Uremic Syndrome (p.Gly1110Ala) with Autoimmune Disease. Park S; Lee YJ; Kim YW; Ko J; Park JH; Kim IH; Kim HJ; Oh D; Park BS Am J Case Rep; 2020 May; 21():e922567. PubMed ID: 32361709 [TBL] [Abstract][Full Text] [Related]
3. The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring. Mannucci PM; Cugno M Thromb Res; 2015 Nov; 136(5):851-4. PubMed ID: 26386489 [TBL] [Abstract][Full Text] [Related]
4. [Atypical HUS caused by complement-related abnormalities]. Yoshida Y; Matsumoto M Rinsho Ketsueki; 2015 Feb; 56(2):185-93. PubMed ID: 25765799 [TBL] [Abstract][Full Text] [Related]
5. A novel quantitative hemolytic assay coupled with restriction fragment length polymorphisms analysis enabled early diagnosis of atypical hemolytic uremic syndrome and identified unique predisposing mutations in Japan. Yoshida Y; Miyata T; Matsumoto M; Shirotani-Ikejima H; Uchida Y; Ohyama Y; Kokubo T; Fujimura Y PLoS One; 2015; 10(5):e0124655. PubMed ID: 25951460 [TBL] [Abstract][Full Text] [Related]
6. Serological and genetic complement alterations in infection-induced and complement-mediated hemolytic uremic syndrome. Westra D; Volokhina EB; van der Molen RG; van der Velden TJ; Jeronimus-Klaasen A; Goertz J; Gracchi V; Dorresteijn EM; Bouts AH; Keijzer-Veen MG; van Wijk JA; Bakker JA; Roos A; van den Heuvel LP; van de Kar NC Pediatr Nephrol; 2017 Feb; 32(2):297-309. PubMed ID: 27718086 [TBL] [Abstract][Full Text] [Related]
7. Safety and effectiveness of eculizumab for adult patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance. Kato H; Miyakawa Y; Hidaka Y; Inoue N; Ito S; Kagami S; Kaname S; Matsumoto M; Mizuno M; Matsuda T; Shimono A; Maruyama S; Fujimura Y; Nangaku M; Okada H Clin Exp Nephrol; 2019 Jan; 23(1):65-75. PubMed ID: 29959568 [TBL] [Abstract][Full Text] [Related]
8. Novel Complement Factor B Gene Mutation Identified in a Kidney Transplant Recipient with a Shiga Toxin-Triggered Episode of Thrombotic Microangiopathy. Korzycka J; Pawłowicz-Szlarska E; Masajtis-Zagajewska A; Nowicki M Am J Case Rep; 2022 Oct; 23():e936565. PubMed ID: 36306276 [TBL] [Abstract][Full Text] [Related]
9. Safety and effectiveness of eculizumab for pediatric patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance. Ito S; Hidaka Y; Inoue N; Kaname S; Kato H; Matsumoto M; Miyakawa Y; Mizuno M; Okada H; Shimono A; Matsuda T; Maruyama S; Fujimura Y; Nangaku M; Kagami S Clin Exp Nephrol; 2019 Jan; 23(1):112-121. PubMed ID: 30039480 [TBL] [Abstract][Full Text] [Related]
13. [Atypical hemolytic uremic syndrome (aHUS): new insights into pathogenesis leading to novel therapeutic approaches]. Kistler AD Praxis (Bern 1994); 2016 Mar; 105(7):389-96. PubMed ID: 27005733 [TBL] [Abstract][Full Text] [Related]
14. Atypical Hemolytic Uremic Syndrome: A Meta-Analysis of Case Reports Confirms the Prevalence of Genetic Mutations and the Shift of Treatment Regimens. Krishnappa V; Gupta M; Elrifai M; Moftakhar B; Ensley MJ; Vachharajani TJ; Sethi SK; Raina R Ther Apher Dial; 2018 Apr; 22(2):178-188. PubMed ID: 29250893 [TBL] [Abstract][Full Text] [Related]
15. Pediatric atypical hemolytic-uremic syndrome due to auto-antibodies against factor H: is there an interest to combine eculizumab and mycophenolate mofetil? Matrat L; Bacchetta J; Ranchin B; Tanné C; Sellier-Leclerc AL Pediatr Nephrol; 2021 Jun; 36(6):1647-1650. PubMed ID: 33774745 [TBL] [Abstract][Full Text] [Related]